Minerva Neurosciences (NERV) Misses Q4 EPS by 3c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($0.34), $0.03 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Goldman's Garrett sees investors dialing back tech exposure into H2
• SAP freezes hiring and travel to fund ’significant’ AI push - Reports
• Aecon wins $1.7B share of Alberta power plant contract